Rosen Law Firm Urges Investors in PROCEPT BioRobotics to Act Quickly
News provided byPROCEPT BioRobotics Corporation · 2 min read
New York, New York, Rosen Law Firm, a leading investor rights law firm, is urging investors who purchased common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024, and February 25, 2026, to secure legal counsel before the important September 22, 2026, deadline for the securities class action lawsuit.
Rosen Law Firm notes that investors who purchased PROCEPT common stock during this period may be eligible for compensation through a contingency fee arrangement, meaning they do not have to pay any out-of-pocket fees or costs. To join the class action, investors can visit the firm’s website at https://rosenlegal.com/cases/procept-biorobotics-corporation/join or contact Phillip Kim, Esq., toll-free at 866-767-3653 or via email at [email protected].
According to the lawsuit, the company and its executives made false and misleading statements during the Class Period, failing to disclose that Procept had utilized an extensive discount program to incentivize bulk orders, which artificially inflated reported U.S. handpiece unit sales and revenues. The lawsuit further alleges that this discount program led to customer orders exceeding underlying procedure demand, causing a surplus of field inventory and overstocking, with more than 10,000 excess units by the end of the Class Period.
The complaint also states that Procept's revenue guidance for 2025 lacked a reasonable factual basis, as the company was acutely exposed to material risks of operational and financial harm. When the truth emerged, the lawsuit claims, investors suffered significant damages.
Rosen Law Firm, known for its track record in leading securities class actions, has represented investors in numerous high-profile cases, securing billions of dollars for clients. The firm has been ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has achieved a $438 million settlement in 2019 alone. Founder Laurence Rosen was named a Titan of the Plaintiffs' Bar by law360 in 2019.
Investors who purchased PROCEPT BioRobotics Corporation stock during the Class Period and wish to serve as lead plaintiff must file with the court no later than September 22, 2026. Failure to act in a timely manner may impact their ability to recover.
Follow the Rosen Law Firm for updates on LinkedIn, Twitter, and Facebook to stay informed about the latest developments in the case.
Attorney Advertising. Prior results do not guarantee a similar outcome.